ID: ALA3121618

Max Phase: Preclinical

Molecular Formula: C17H12O6

Molecular Weight: 312.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)COc1cc(O)cc2oc(-c3ccccc3)cc(=O)c12

Standard InChI:  InChI=1S/C17H12O6/c18-11-6-14(22-9-16(20)21)17-12(19)8-13(23-15(17)7-11)10-4-2-1-3-5-10/h1-8,18H,9H2,(H,20,21)

Standard InChI Key:  MLKUTAWBHKBHET-UHFFFAOYSA-N

Associated Targets(non-human)

H22 575 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 312.28Molecular Weight (Monoisotopic): 312.0634AlogP: 2.63#Rotatable Bonds: 4
Polar Surface Area: 96.97Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.72CX Basic pKa: CX LogP: 1.98CX LogD: -2.38
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.77Np Likeness Score: 0.74

References

1. Zhu ZY, Wang WX, Wang ZQ, Chen LJ, Zhang JY, Liu XC, Wu SP, Zhang YM..  (2014)  Synthesis and antitumor activity evaluation of chrysin derivatives.,  75  [PMID:24556144] [10.1016/j.ejmech.2013.12.044]

Source